SCHEMBL19429013

SCHEMBL19429013

c1ccc(N(c2ccccc2)c2cccc(N(c3ccc4sc5ccccc5c4c3)c3ccc4sc5ccc(N(c6ccccc6)c6ccccc6)cc5c4c3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.48
CYP1A2 P05177 2/20 0.41
MAPT P10636 6/20 0.41
ALDH1A1 P00352 6/20 0.41
RAB9A P51151 3/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN7 P35236 1/20 0.39
DUSP3 P51452 1/20 0.39
PTPN12 Q05209 1/20 0.39
PTPN22 Q9Y2R2 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGIR P43119 1/20 0.38
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15730656 1.00 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL19801783 1.00 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL19801847 1.00 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL14295429 1.00 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL19801784 1.00 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL17369933 0.97 GPR3 (0.48) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL23314347 0.96 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL18928088 0.96 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL15730671 0.96 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A
SCHEMBL12936134 0.96 GPR3 (0.52) GPR3CYP1A2MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230009845-A1 ORGANIC ELECTRIC ELEMENT COMPRISING A PLURALITY OF EMISSION-AUXILIARY LAYERS AND ELECTRONIC DEVICE COMPRISING IT DUK SAN NEOLUX CO., LTD. (KR) 2023-01-12 US disclosed
US-20210184129-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-06-17 US disclosed
US-10573819-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-02-25 US disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2017-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573819-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof OCIAD1, GPX1, PIEZO1 GPR3 4817/4885CYP1A2 885/4885MAPT 2496/4885
US-20170288148-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF OCIAD1, GPX1, PIEZO1 GPR3 4817/4885CYP1A2 885/4885MAPT 2496/4885
US-20210184129-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF OR51E2, SLC39A11, WEE1 GPR3 4852/4885CYP1A2 3744/4885MAPT 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.